The/DT
normal/JJ
cell/NN
cycle/NN
activation/NN
program/NN
is/VBZ
exploited/VBN
during/IN
the/DT
infection/NN
of/IN
quiescent/JJ
B/NN
lymphocytes/NNS
by/IN
Epstein-Barr/JJ
virus/NN
./.

B/NN
lymphocytes/NNS
in/IN
the/DT
peripheral/JJ
circulation/NN
are/VBP
maintained/JJ
in/IN
a/DT
non-proliferative/JJ
state/NN
./.
=====
Antigen/NN
recognition/NN
stimulates/VBZ
limited/JJ
proliferation/NN
,/,
whereas/IN
infection/NN
with/IN
Epstein-Barr/JJ
virus/NN
(/(
EBV/NN
)/)
results/VBZ
in/IN
continual/JJ
proliferation/NN
and/CC
the/DT
outgrowth/NN
of/IN
immortal/JJ
cell/NN
lines/NNS
./.
=====
Because/IN
it/PRP
is/VBZ
not/RB
clear/JJ
at/IN
which/WDT
point/NN
in/IN
cell/NN
cycle/NN
the/DT
peripheral/JJ
B/NN
lymphocytes/NNS
are/VBP
arrested/VBN
,/,
we/PRP
characterized/VBD
the/DT
expression/NN
of/IN
several/JJ
cell/NN
cycle-associated/JJ
genes/NNS
in/IN
quiescent/JJ
and/CC
stimulated/VBN
cells/NNS
./.
=====
We/PRP
show/VBP
that/IN
the/DT
expression/NN
of/IN
four/CD
cell/NN
genes/NNS
,/,
cdc-2/NN
,/,
cyclin/NN
E/NN
,/,
CD23/NN
,/,
and/CC
cyclin/NN
D2/NN
,/,
are/VBP
up-regulated/VBN
approximately/RB
100-fold/RB
as/IN
a/DT
result/NN
of/IN
EBV-mediated/JJ
immortalization/NN
./.
=====
Because/IN
these/DT
genes/NNS
play/VBP
a/DT
positive/JJ
role/NN
in/IN
cell/NN
proliferation/NN
,/,
we/PRP
suggest/VBP
that/IN
this/DT
regulatory/JJ
switch/NN
contributes/VBZ
to/TO
controlling/VBG
entry/NN
into/IN
the/DT
cell/NN
cycle/NN
./.
=====
Transient/JJ
stimulation/NN
of/IN
quiescent/JJ
B/NN
lymphocytes/NNS
with/IN
either/CC
a/DT
cocktail/NN
of/IN
anti-CD40/NN
,/,
anti-IgM/NN
,/,
and/CC
IL4/NN
,/,
or/CC
EBV/NN
results/VBZ
in/IN
the/DT
rapid/JJ
expression/NN
of/IN
the/DT
same/JJ
four/CD
genes/NNS
,/,
suggesting/VBG
that/IN
,/,
after/IN
infection/NN
,/,
EBV/NN
exploits/VBZ
the/DT
normal/JJ
program/NN
of/IN
B-lymphocyte/NN
cell/NN
cycle/NN
activation/NN
./.